Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.
about
Are we getting closer to the treatment of rabies?Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infectionDifferential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissuesNovel Approaches to the Prevention and Treatment of RabiesSelection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1.Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers.The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.Neutralizing antibodies in persistent borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitisProlonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in miceProtective effect of different anti-rabies virus VHH constructs against rabies disease in mice.The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.Control of central nervous system viral persistence by neutralizing antibody.Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.Presence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogsNew aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States.Recombinant human IgA expressed in insect cells.Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.Virology, immunology and pathology of human rabies during treatmentPerspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from PathogenesisTau-based treatment strategies in neurodegenerative diseasesImmunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathologyIntrathecal humoral immunity to encephalitic RNA viruses.Immune responses to non-tumor antigens in the central nervous system.Immunological aspects of rabies: a literature review.Survival of rabid rabbits after intrathecal immunization.Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.Neutralizing antibodies in Borna disease virus-infected rats.Neutralization of respiratory syncytial virus after cell attachment.MHC class II DRB diversity in raccoons (Procyon lotor) reveals associations with raccoon rabies virus (Lyssavirus).SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine
P2860
Q22305767-90A632C9-6609-4749-AAB0-9B1D1B245654Q24675760-0526E903-5BF5-4085-AAFE-DE68E17641AFQ28582116-DB237B71-7941-4E82-AB14-F890EBC4D775Q28818601-0C753B61-48A0-457E-BE91-D05501B93816Q30692734-BB85D2C9-6D64-46AA-8A06-CF63E9063861Q33471421-4DD74111-2EEE-4ABC-A7F5-518B64D6E6CDQ33508816-5E53E92B-1901-4836-9D9A-FFE46BD5CAA2Q33514828-43051513-AC8D-4949-B449-9422CE7F4237Q33542433-A29439B4-96A1-4608-A5D6-6BB7360AC51AQ33786378-362BAD17-856F-4165-9077-B6AEC51AA1C2Q33835749-011E7844-35CA-4506-ACAE-99A8FADC33DAQ33852821-3B508CCF-7AD9-4ADE-8F78-06CBC0E24E67Q33987410-69AAAC8F-FD7C-404E-AFC3-6D9833BBA67AQ34120270-FEDE867B-2877-4CE6-91A2-0EE3708FBA35Q34228539-2821BEAB-0356-4F24-B4DA-26737049A24DQ34408085-5DB5F696-ECB1-4AF5-BBB7-FEA8D3244192Q34467281-07FEE4F2-F29F-448F-BA0F-27E080A0713AQ34859605-013C3840-F1ED-4590-A742-5773DB0E5962Q34992598-EFC3CF30-C1FF-45D2-80B0-A649C0209B7AQ34999794-0F0FE303-518C-4C7A-800E-69D3ACEA2413Q35370075-BF52BA74-69B0-44BA-8112-3042F708B849Q35698255-EB6CB766-289F-4350-9D95-B620585772D8Q35881226-A282E7C0-1526-44FB-BCA3-1EC7B5CF7926Q35886309-77A33AF9-515E-4A36-863F-C51C7EBF670FQ36734427-ED3ABA97-0A02-4794-99D4-8D81244AB4D7Q37136492-B615E81E-00FB-4D54-85F3-427603894B77Q37215861-0F83C991-34B6-4DB7-AC37-D916335C63ABQ37308949-396E68AC-2F68-4211-831A-178F18DD817AQ37311364-1E8EE43B-81E8-4CF4-9C1C-648489C851E4Q38084075-8755ED89-806B-45DB-92A4-2971ABA506E6Q38272285-093997CF-F49D-49DD-915D-E0F212415926Q38654706-4B5D9958-7036-466B-B37F-664FB4E73094Q39278121-0F63415E-C0F0-41FC-8260-638CEA87B974Q39578252-CA48B26E-0B8E-4EA7-A93D-290F6DBFA3A0Q39789318-7D7D6FAF-B6D9-455B-AD09-44876D0E6B1DQ39868631-BC222876-9A5E-465D-9E46-B0E1483CAF12Q39868901-491BD7F2-107C-481F-B4CD-DA54F572A28BQ45372541-C4F146B2-E25D-407F-8ED9-964FC37F7009Q47562878-5189FE0D-ACBD-4B12-9C10-FC39A06CAA16Q56967894-7FEB7430-AE20-42C0-8392-30AB1AF0282A
P2860
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delineation of putative mechan ...... om the central nervous system.
@en
Delineation of putative mechan ...... om the central nervous system.
@nl
type
label
Delineation of putative mechan ...... om the central nervous system.
@en
Delineation of putative mechan ...... om the central nervous system.
@nl
prefLabel
Delineation of putative mechan ...... om the central nervous system.
@en
Delineation of putative mechan ...... om the central nervous system.
@nl
P2093
P2860
P356
P1476
Delineation of putative mechan ...... om the central nervous system.
@en
P2093
B Dietzschold
C E Rupprecht
H Koprowski
P2860
P304
P356
10.1073/PNAS.89.15.7252
P407
P577
1992-08-01T00:00:00Z